Properties
Description
Ixazomib citrate interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Formula
C20H23BCl2N2O9
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ixazomib citrate is used in research targeting the proteasome, which is responsible for degrading damaged proteins, relevant to cancer treatment.